Machine learning-based early survival prediction in early-onset hepatocellular carcinoma: a SEER-based multi-model
Huan Ma1, Zhenpeng Zeng1, Chenjie Xiao1
1Department of Interventional Therapy, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, China.
Translational Cancer Research
|May 25, 2026
Summary
Machine learning models accurately predict early survival in early-onset hepatocellular carcinoma (eHCC) patients. The random forest model, identifying surgical intervention as key, outperforms traditional staging for improved risk stratification.
Area of Science:
- Oncology
- Machine Learning in Medicine
- Biostatistics
Background:
- Early-onset hepatocellular carcinoma (eHCC) presents unique clinical challenges.
- Prognostic factors for eHCC survival are not well understood.
- There is a need for improved predictive models for eHCC.
Purpose of the Study:
- To develop and validate machine learning (ML) models for predicting early survival in eHCC patients.
- To identify key prognostic factors influencing eHCC survival.
- To compare ML model performance against the AJCC staging system.
Main Methods:
- Utilized the SEER database (2010-2021) for eHCC patient data.
- Developed and compared five ML algorithms (MLP, LR, SVM, RF, XGBoost) and an AJCC staging model.
- Assessed model performance using AUC, accuracy, precision, recall, F1 score, and SHAP for variable importance.
Main Results:
- The Random Forest (RF) model achieved an AUC of 0.80 in the validation cohort, outperforming the AJCC model (AUC 0.66).
- RF model metrics included 0.72 accuracy, 0.71 precision, 0.81 recall, and 0.75 F1 score.
- SHAP analysis identified surgical intervention as the most significant predictor in the RF model.
Conclusions:
- The validated RF model demonstrates strong predictive ability for early survival in eHCC.
- This ML-based approach can enhance risk stratification for eHCC patients.
- The findings support the use of ML models to guide individualized treatment decisions in eHCC.

